Mary CEO ‘Not Too Concerned’ About China’s CBD Cosmetics Ban
Executive Summary
Mary Agrotechnologies CEO Frank Qin says he is “not too concerned” about China's recent CBD cosmetics ban, despite his company's plans to build a 150,000 square-foot cultivation and extraction plant in Yunnan, with the aim of supplying the domestic CBD market and exporting overseas.
You may also be interested in...
China’s CBD Cosmetics Shutdown Not Harshing Yooma’s Mellow
Yooma Wellness, a producer of cannabinoid ingredients and owner of brands including What the Hemp, says better-than-expected growth in other markets should offset the impact of China’s ban on CBD in cosmetics.
UK FSA Finalizes Public CBD List Comprising Almost 12,000 Products
The UK Food Standards Agency has published the final update to its public CBD list following what Canna Consultants' Matt Lawson describes as a regulatory “baptism of fire.” There are now 11,908 products permitted to remain on the UK market once those classed as “removed” are taken into account. These products will either progress to the “validated” stage of the UK's novel food process or also be removed.
Digital Home-Testing Is The Future, Says Bloom Diagnostics Co-Founder Angelica Kohlmann
With its lateral flow at-home tests for ferritin, thyroid function and ovarian reserves, Swiss medtech firm Bloom Diagnostics thinks it has seen the future of consumer healthcare. HBW Insight speaks to co-founder and board chair Angelica Kohlmann about the firm's Bloom Lab technology and forward-looking plans, including a possible US launch.